Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
AI Capital
DenverSeries A–Growth
10 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
7 people
GC Ventures
BangkokSeed–Growth
7 people
Thursday Ventures
BrandonSeed–Series C
7 people
Beiersdorf Innovation Fund
HamburgSeed–Growth$550K – $5.5M
6 people
CCV Capital
BeijingSeed–Series B
14 people
OCV Partners
Los AngelesSeed–Series C
6 people
Socii Capital
San FranciscoSeries A–Series B
6 people
Tenacity Ventures
BengaluruSeed–Growth$10M
6 people
Recharge Thematic Ventures Management Llc
New YorkSeed–Late Stage
8 people
Access Biotechnology
New YorkSeed–Late Stage
3 people
Deep Insight
Tel AvivPre-Seed–Late Stage
6 people
Wallonie Entreprendre
LiègePre-Seed–Growth
9 people
Globivest
Pre-Seed–Series B
5 people
Overlap Holdings
HicksvilleSeed–Series B
6 people
Orbia Ventures
BostonSeed–Series B$1M – $6M
6 people
Shenzhen Capital Group
ShenzhenSeed–Growth$1M – $3.5M
3 people
NYBC Ventures
New YorkSeed–Series B
8 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
2 people
Highlight Capital
NanjinSeed–Series B
1 person
Oita Venture Capital
OitaPre-Seed–Growth
1 person
Criteria Bio Ventures
BarcelonaSeed–Series B
7 people
Nourish Ventures
Seed–Series B
10 people
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.



















































































